New demands of the United States under the Free Trade Agreement: pharmaceutical patents
Keywords:
Transnational corporations, intellectual property, patents, pharmaceuticals, knowledgeAbstract
This article is focused on the intellectual property disciplines demanded by the US to Ecuador in the process of negotiating the US-Andean Free Trade Agreement. These demands go further than Andean intellectual property norms, which are actually very favorable to the pharmaceutical corporations. Basically the US requests are related to the protection of exclusivity rights applied to non-divulgated information; conditions for obligatory licenses; enhancing time protections to patents and second uses; and elimination of constraints to patentability. It is concluded that the intellectual property debate is essentially a political issue, although it appears as a technical matter.
Downloads
Downloads
How to Cite
Issue
Section
License
Authors who publish in this journal accept the following conditions:
1. The authors keep the copyright and assign to the journal Comentario Internacional the right of the first publication, with the work registered with the attribution license of Creative Commons, which allows third parties to use what is published whenever they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual arrangements for the non-exclusive distribution of the article published in this journal (eg, include it in an institutional repository or publish it in a book) provided they clearly indicate that the work was published for the first time in Comentario Internacional.